Lead Plaintiff Deadline: November 16, 2020
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
(1) Nano-X’s commercial agreements and its customers were fabricated; (2) Nano-X’s statements regarding its “novel” Nanox System were misleading as the Company never provided data comparing its images with images from competitors’ machines; (3) Nano-X’s submission to the U.S. Food and Drug Administration admitted the Nanox System was not original; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.
In order to be included in the lawsuit, you must have incurred a loss on shares of Nano-X purchased or acquired during the class period listed above.
If you suffered a loss in Nano-X during the relevant time frame, you have until November 16, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.